Collegium Pharma (COLL) –
-
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
-
Collegium Pharma (COLL) to Redeem Certain Convertible Notes
-
Form 8-K COLLEGIUM PHARMACEUTICAL For: Apr 11
-
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
-
Form ARS COLLEGIUM PHARMACEUTICAL For: Dec 31
-
Form DEFA14A COLLEGIUM PHARMACEUTICAL
-
Form DEF 14A COLLEGIUM PHARMACEUTICAL For: May 16
-
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
-
Form 4 COLLEGIUM PHARMACEUTICAL For: Feb 29 Filed by: Smith Thomas B
-
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Smith Thomas B
-
Form 4 COLLEGIUM PHARMACEUTICAL For: Feb 26 Filed by: Dreyer Scott
-
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Dreyer Scott
-
Collegium Pharmaceutical (COLL) PT Raised to $40 at Truist Securities
-
Collegium Pharmaceutical (COLL) PT Raised to $39 at Piper Sandler
-
Collegium Pharma (COLL) Tops Q4 EPS by 15c; offers guidance
-
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
-
Form 10-K COLLEGIUM PHARMACEUTICAL For: Dec 31
-
Form 8-K COLLEGIUM PHARMACEUTICAL For: Feb 22
-
Form 4 COLLEGIUM PHARMACEUTICAL For: Feb 12 Filed by: Tupper Colleen
-
Form 4 COLLEGIUM PHARMACEUTICAL For: Feb 12 Filed by: Dreyer Scott
-
Form 4 COLLEGIUM PHARMACEUTICAL For: Feb 12 Filed by: Kuhlmann Shirley R.
-
Form 4 COLLEGIUM PHARMACEUTICAL For: Feb 12 Filed by: Smith Thomas B
-
Form 4 COLLEGIUM PHARMACEUTICAL For: Feb 12 Filed by: Ciaffoni Joseph
-
Form SC 13G/A COLLEGIUM PHARMACEUTICAL Filed by: EVENTIDE ASSET MANAGEMENT, LLC
-
Form SC 13G/A COLLEGIUM PHARMACEUTICAL Filed by: VANGUARD GROUP INC
-
Form SC 13G/A COLLEGIUM PHARMACEUTICAL Filed by: Rubric Capital Management LP
-
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
-
Form SC 13G/A COLLEGIUM PHARMACEUTICAL Filed by: BlackRock Inc.
-
Form 4 COLLEGIUM PHARMACEUTICAL For: Jan 16 Filed by: Dreyer Scott
-
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Dreyer Scott
-
Jefferies Downgrades Collegium Pharmaceutical (COLL) to Hold, 'Well-Played Cap Deployment Strategy Yields Windfall for Investors'
-
Collegium Pharmaceutical (COLL) PT Raised to $37 at Truist Securities
-
Form 8-K COLLEGIUM PHARMACEUTICAL For: Jan 01
-
Collegium Pharma (COLL) Provides 2024 Financial Guidance
-
Collegium Provides 2024 Financial Guidance
-
Form 4 COLLEGIUM PHARMACEUTICAL For: Dec 21 Filed by: Ciaffoni Joseph
-
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Ciaffoni Joseph
-
Form 4 COLLEGIUM PHARMACEUTICAL For: Dec 18 Filed by: Ciaffoni Joseph
-
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Ciaffoni Joseph
-
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Ciaffoni Joseph
-
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Ciaffoni Joseph
-
Form 4 COLLEGIUM PHARMACEUTICAL For: Nov 27 Filed by: Kuhlmann Shirley R.
-
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Kuhlmann Shirley R.
-
Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
-
Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
-
Form 8-K COLLEGIUM PHARMACEUTICAL For: Nov 09
-
Collegium Pharma (COLL) Announces $25M Accelerated Share Buyback
-
Collegium Announces $25 Million Accelerated Share Repurchase Program
-
Collegium to Participate in Upcoming Investor Conferences
-
Collegium Pharma (COLL) Tops Q3 EPS by 9c
Back to COLL Stock Lookup